Can class action lawsuit alleging false statements drive Hims & Hers Health stock lower?

Traders Union
All News
Stocks
Hims & Hers slides 3.3% today

Highlights

Hims & Hers Health faces a securities class action lawsuit over alleged false statements about data-sharing and billing practices for prescription services.
The litigation introduces direct legal risk and may increase uncertainty regarding the company reputation among investors.
Shares of Hims & Hers Health fell 3.3% to $27.85 and trade below key moving averages, with technical signals favoring a move to the $26.7 to $29 range and a high likelihood of further declines.

Litigation risk grows as lawsuit alleges disclosure failures

A securities class action lawsuit has been filed against Hims & Hers Health, Inc., alleging the company provided false and misleading statements regarding its data-sharing practices and billing processes related to prescription services, according to Globenewswire. The initiation of this legal proceeding presents direct litigation risk and may contribute to uncertainty around the company's reputation. Heightened scrutiny from investors is likely as the case develops, further impacting market sentiment toward HIMS stock.

Bearish bias persists as technicals confirm downside momentum

On the technical side, HIMS is trading below the MA-20 at $28.22 and MA-50 at $27.92 on the hourly chart, as well as beneath the MA-200 at $28.14 on the daily timeframe. The nearest resistance is set by the Ichimoku Kijun at $28.09, with notable support near $26.7. Momentum indicators show mixed short-term signals: MACD is firmly bullish, but the ADX and Awesome Oscillator are neutral, while RSI reads 45.29, reflecting a bearish bias. Stochastic RSI remains oversold, CCI is neutral, and Bull/Bear Power continues to favor sellers, collectively confirming that downside pressure persists.

Downside risk prevails as volatility constrains rebounds

In the short term, price action for HIMS is likely to remain volatile between $26.7 and $29. There is a very high probability of a downward move pushing through the $26.7 support, while any meaningful rebound appears to carry a very low probability unless price can break decisively above $28.09 resistance. The baseline scenario keeps trading contained within this volatility band, with further downside action more likely.

Anton Kharitonov, expert at Traders Union, sees the current setup for Hims & Hers Health, Inc. as highly defensive. Legal risks from the class action lawsuit and selling pressure below key moving averages combine to create a strongly negative sentiment. Technical signals confirm the bearish bias, with support at $26.7 vulnerable and little chance for a rebound unless $28.09 is reclaimed. "Given the unresolved litigation and persistent downside momentum, I remain defensive on HIMS until clear bullish signals emerge above resistance."

Earlier, analysts noted that persistent legal risks and sustained technical weakness were weighing on Hims & Hers Health shares. With fresh class action allegations focused on data-sharing and billing practices, the litigation overhang deepens and puts the $26.70 support level in sharper focus as a key downside risk for traders.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.